Timothy Kercher
32Patents
8h-index
76Co-inventors
74Inventor score
Filing activity: Jul 21, 2006 → Dec 13, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8791123B2 | Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors | Emerging Cross-Sectional Technologies | 68 | Active |
| US8299021B2 | Macrocyclic inhibitors of hepatitis C virus replication | Emerging Cross-Sectional Technologies | 45 | Active |
| US7829665B2 | Macrocyclic inhibitors of hepatitis C virus replication | Emerging Cross-Sectional Technologies | 19 | Active |
| US9782415B2 | Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors | Emerging Cross-Sectional Technologies | 19 | Active |
| US9796724B2 | Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors | Emerging Cross-Sectional Technologies | 16 | Active |
| US10357489B2 | Antiproliferative compounds and methods of use thereof | Human Necessities | 12 | Active |
| US11149007B2 | Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 10 | Active |
| US11325889B2 | Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 9 | Active |
| US9562055B2 | Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors | Emerging Cross-Sectional Technologies | 6 | Active |
| US7781474B2 | Inhibitors of hepatitis C virus replication | Chemistry; Metallurgy | 6 | Active |
| US11185543B2 | Antiproliferative compounds and methods of use thereof | Human Necessities | 4 | Active |
| US10251889B2 | Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors | Emerging Cross-Sectional Technologies | 3 | Active |
| US9878997B2 | Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors | Emerging Cross-Sectional Technologies | 3 | Active |
| US9896435B2 | N-pyrrolidinyl,N′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors | Chemistry; Metallurgy | 2 | Active |
| US11873283B2 | Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 1 | Active |
| US10323022B2 | Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors | Emerging Cross-Sectional Technologies | 1 | Active |
| US10351575B2 | Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain | Chemistry; Metallurgy | 1 | Active |
| US12029738B2 | Antiproliferative compounds and methods of use thereof | Human Necessities | 0 | Active |
| US11945804B2 | Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 0 | Active |
| US9822118B2 | Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10889589B2 | Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain | Chemistry; Metallurgy | 0 | Active |
| US11358952B2 | Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 0 | Active |
| US11878976B2 | FGFR3 inhibitor compounds | Chemistry; Metallurgy | 0 | Active |
| US12404241B2 | Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 0 | Active |
| US8962596B2 | 5,7-substituted-imidazo[1,2-C]pyrimidines as inhibitors of JAK kinases | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.